AVITA Medical (RCEL) Gross Margin Growth (3y) (2021 - 2025)
AVITA Medical (RCEL) Gross Margin Growth (3y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.32 Bn | 174.03 Bn | 6.27 Bn | 63.00 |
| 2 | Stryker | 128.59 Bn | 125.71 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 21.00 |
| 4 | Boston Scientific | 67.77 Bn | 66.32 Bn | 3.61 Bn | 15.00 |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.46 Bn | 1.29 Bn | -324.00 |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.15 Bn | 1.98 Bn | -164.00 |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 56.00 |
| 8 | Smith & Nephew | 26.77 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.24 Bn | 22.11 Bn | 2.07 Bn | 311.00 |
| 10 | AVITA Medical | 135.40 Mn | 119.06 Mn | 14.31 Mn | -7,020.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7,020.00 |
| Sep 30, 2025 | -106.00 |
| Mar 31, 2025 | 916.00 |
| Sep 30, 2024 | 394.00 |
| Jun 30, 2024 | 813.00 |
| Mar 31, 2024 | 1,086.00 |
| Dec 31, 2023 | 344.00 |
| Sep 30, 2023 | 287.00 |
| Jun 30, 2023 | 379.00 |
| Mar 31, 2023 | 55.00 |
| Dec 31, 2022 | 1,171.00 |
| Sep 30, 2022 | 222.00 |
| Mar 31, 2022 | -651.00 |
| Sep 30, 2021 | 6,598.00 |